INTERNATIONAL JOURNAL OF HEALTH RESEARCH AND DEVELOPMENT (IJHRD)

URODYNAMIC PARAMETERS IN SPINAL CORD INJURY- INDUCED NEUROGENIC BLADDER RATS AFTER STEM CELL TRANSPLANTATION: A NARRATIVE REVIEW

E-ISSN: 7883-6773

P-ISSN: 3457-2861

DOI: https://iigdpublishers.com/article/108

Neurogenic bladder (NGB) secondary to spinal cord injury (SCI) is accompanied with several complications such as urinary tract deterioration, urinary incontinence, and consequently lower quality of life (QoL), significant morbidities, and occasionally death. Current therapeutic methods have some side effects and there is no treatment for the upper urinary tract injuries. Stem cell therapy is a promising method for treating this condition. However, the best timing and the best route of its transplantation have not yet been determined. Animal models of SCI, especially in rats, are the most commonly used method for evaluating the efficacy of cell therapy in NGB improvement, and the most common assessment method is the urodynamic studies (UDS). However, there are variations in the range of UDS parameters among the published studies. The current review aimed to discuss the effect of stem cell transplantation on bladder dysfunction recovery based on urodynamic parameters after SCI in rats. For this purpose, the cell source, doses, the route of administration, and the complete UDS equipment and its parameters were summarized in SCI models in rats. In some urodynamic test results, to some extent, an improvement in the lower urinary system function was observed in each treatment group. However, this improvement was far from full functional recovery. The average cell dose was about 1 million cells in every injected site. In most studies, the stem cells (SCs) were transplanted 9 days after the injury using PE-50 and PE-60. Many researchers have
recommended further experimental and clinical studies to confirm this treatment modality.

Keyword(s) Urodynamic, Spinal Cord Injuries, Urinary Bladder, Neurogenic, Stem Cell Transplantation.
About the Journal VOLUME 6, ISSUE 1 | June 2023
Quality GOOD

Nasrin Abolhasanpour

Linder A, Leach GE, Raz S. Augmentation cystoplasty in the treatment of neurogenic bladder dysfunction. J Urol. 1983;129:491-PubMed PMID: 6834530.


Palma JA, Kaufmann H. (2018). Treatment of auto- nomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord.;33:372-90. doi: 10.1002/mds.27344. PubMed PMID: 29508455; PubMed Central PMCID: PMCPMC5844369.


Stoffel JT. Chronic Urinary Retention in Multiple Sclerosis Patients: (2017). Physiology, Systematic Review of Urodynamic Data, and Recommendations for Care. Urol Clin North Am. 2017;44:429-39. doi: 10.1016/j. ucl..04.009. PubMed PMID: 28716323.


Son SB, Chung SY, Kang S, Yoon JS. (2017). Relation of Urinary Retention and Functional Recov- ery in Stroke Patients During Rehabilitation Program. Ann Rehabil Med. 2017;41:204-10. doi: 10.5535/arm.41.2.204. PubMed PMID: 28503452; PubMed Central PMCID: PMCPMC5426277.

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. (2003). The standardi- sation of terminology in lower urinary tract function: report from the standardisation sub- committee of the International Continence Society. Urology;61:37-49. PubMed PMID: 12559262.

article